HomeCompareVBTX vs MRK

VBTX vs MRK: Dividend Comparison 2026

VBTX yields 3.50% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VBTX wins by $831.1K in total portfolio value
10 years
VBTX
VBTX
● Live price
3.50%
Share price
$30.26
Annual div
$1.06
5Y div CAGR
58.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$888.9K
Annual income
$573,207.86
Full VBTX calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — VBTX vs MRK

📍 VBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBTXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBTX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VBTX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBTX
Annual income on $10K today (after 15% tax)
$297.75/yr
After 10yr DRIP, annual income (after tax)
$487,226.68/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, VBTX beats the other by $478,629.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBTX + MRK for your $10,000?

VBTX: 50%MRK: 50%
100% MRK50/50100% VBTX
Portfolio after 10yr
$473.3K
Annual income
$291,660.82/yr
Blended yield
61.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VBTX
Analyst Ratings
6
Buy
4
Hold
Consensus: Buy
Price Target
$30.33
+0.2% upside vs current
Range: $28.00 — $33.00
Altman Z
-0.7
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBTX buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBTXMRK
Forward yield3.50%2.81%
Annual dividend / share$1.06$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR58.8%32.7%
Portfolio after 10y$888.9K$57.7K
Annual income after 10y$573,207.86$10,113.78
Total dividends collected$835.8K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$30.33$128.54

Year-by-year: VBTX vs MRK ($10,000, DRIP)

YearVBTX PortfolioVBTX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,256$556.27$11,213$373.04+$43.00VBTX
2$12,973$929.28$12,667$512.06+$306.00VBTX
3$15,471$1,589.56$14,439$708.14+$1.0KVBTX
4$19,367$2,813.27$16,640$988.16+$2.7KVBTX
5$25,950$5,226.69$19,432$1,394.07+$6.5KVBTX
6$38,160$10,393.37$23,057$1,992.90+$15.1KVBTX
7$63,514$22,682.61$27,889$2,894.79+$35.6KVBTX
8$123,989$56,030.02$34,518$4,286.29+$89.5KVBTX
9$295,001$162,332.73$43,912$6,494.35+$251.1KVBTX
10$888,859$573,207.86$57,714$10,113.78+$831.1KVBTX

VBTX vs MRK: Complete Analysis 2026

VBTXStock

Veritex Holdings, Inc. operates as the bank holding company for Veritex Community Bank that provides various commercial banking products and services to small and medium-sized businesses, and professionals. The company accepts deposit products include demand, savings, money market, and time accounts. Its loan products include commercial real estate and general commercial, mortgage warehouse loans, residential real estate, construction and land, farmland, consumer, paycheck protection program, 1-4 family residential, agricultural, multi-family residential, and consumer loans, as well as purchased receivables financing. The company also provides interest rate swap services; and a range of online banking solutions, such as access to account balances, online transfers, online bill payment and electronic delivery of customer statements, and ATMs, as well as mobile banking, mail, and personal appointment. In addition, it offers debit cards, night depository services, direct deposits, cashier's checks, and letters of credit; treasury management services, including balance reporting, transfers between accounts, wire transfer initiation, automated clearinghouse origination, and stop payments; and cash management deposit products and services consisting of lockbox, remote deposit capture, positive pay, reverse positive pay, account reconciliation services, zero balance accounts, and sweep accounts. As of December 31, 2021, the company operated 18 full-service branches located in the Dallas-Fort Worth metroplex, and 10 full-service branches in the Houston metropolitan area. Veritex Holdings, Inc. was incorporated in 2009 and is headquartered in Dallas, Texas.

Full VBTX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VBTX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBTX vs SCHDVBTX vs JEPIVBTX vs OVBTX vs KOVBTX vs MAINVBTX vs JNJVBTX vs ABBVVBTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.